Key result
Recent studies identifying new molecules on the platelet surface and within platelets provide potential targets for new classes of antiplatelet agents.
Understanding the molecular mechanisms of platelet activation and thrombus regulation provides potential targets for developing novel antiplatelet therapies.
Answers are grounded in this paper and cite their sources.
New platelet targets merit preclinical pursuit; hypothesis-generating and should not yet alter practice.
Platelet activation in vivo can be part of the hemostatic response to injury or a pathological response to disease. In either setting, platelets adhere to the vessel wall and to each other, forming a closely packed mass interspersed with fibrin. Recent studies have identified new molecules on the platelet surface and within platelets that support and regulate thrombus growth and stability, ensuring that platelet accumulation after injury is sufficient to stop bleeding, but not so exuberant that vascular occlusion occurs. An understanding of how this balance is achieved helps to illuminate the events of platelet activation and, at the same time, provides potential targets for new classes of antiplatelet agents.
No takes yet. Share an insight, caveat, or question.
Brass et al. (2008) conducted a review in Platelet activation and thrombosis. Novel antiplatelet targets was evaluated. Recent studies identifying new molecules on the platelet surface and within platelets provide potential targets for new classes of antiplatelet agents.
Synapse has enriched 10 related papers. Consider them for comparative context: